论文部分内容阅读
近几年来,素高捷疗眼膏(SEG)作为治疗角膜病的辅助药物,在临床上获得了较好的疗效。1998年2月～7月,我们使用瑞士生产的SEG辅助治疗角膜病患者40例,现将观察结果报告如下。 1 临床资料 1.1 一般资料:除因眼睑位置异常或倒睫引起的角膜病外的各种角膜疾病患者80例120眼,随机分为两组:对照组40例58眼,男21例、女19例。年龄11～65岁、平均年龄35岁,浅层点状角膜炎12例20眼、细菌性角膜溃疡8例10眼、单纯疱疹性角膜炎6例9眼、外伤性角膜上皮缺损4例6眼、化学性角膜烧伤3例6眼、角膜穿透伤7例7眼,就诊最短时间
In recent years, the treatment of eye drops SAG (SEG) as a supplementary treatment of corneal disease, clinically achieved good results. February 1998 ~ July, we use the Swiss-produced SEG-assisted treatment of 40 patients with corneal disease, the observations are reported below. 1 Clinical data 1.1 General Information: In addition to corneal disease due to abnormal eyelid or trichiasis caused by corneal disease in 80 patients with 120 eyes, were randomly divided into two groups: the control group of 40 patients 58 eyes, 21 males and 19 females example. Aged 11-65 years, mean age 35 years old, 12 cases of superficial punctate keratitis in 20 eyes, 8 cases of bacterial corneal ulcer in 10 cases, 6 cases of herpes simplex keratitis in 6 cases, 4 cases of traumatic corneal epithelial defect in 6 cases , Chemical corneal burns in 3 cases 6 eyes, corneal penetrating injury in 7 cases 7 eyes, the shortest treatment time